Asthma exacerbations · 1: Epidemiology

Thorax

Volumn 61, Issue 8, 2006, Pages 722-728

  Johnston, N W ^a   Sears, M R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; PLACEBO; ANTIASTHMATIC AGENT;

AIR POLLUTANT; AIR POLLUTION; AMBIENT AIR; ASTHMA; ATMOSPHERE; CLIMATE; CLINICAL TRIAL; DEATH; DISEASE CONTROL; DISEASE EXACERBATION; EMERGENCY CARE; ENVIRONMENTAL FACTOR; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; MORBIDITY; MORTALITY; NONHUMAN; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RHINOVIRUS; RISK FACTOR; SCHOOL; SEASONAL VARIATION; VIRAL RESPIRATORY TRACT INFECTION; WORKPLACE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTION; SEASON; SEX RATIO;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE DISTRIBUTION; AGED; ANTI-ASTHMATIC AGENTS; ASTHMA; CANADA; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; SEASONS; SEX DISTRIBUTION;

EID: 33747039245     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.045161     Document Type: Review

References (63)

1. Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med 2006;100:434-50.
2. Skrepnek GH, Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004;10(5 Suppl):S129-38.
3. Andersson F, Borg S, Stahl E. The impact of exacerbations on the asthmatic patient's preference scores. J Asthma 2003;5:615-23.
4. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-11.
5. Johnston NW, Sears MR. Seasonal patterns of asthma exacerbations. In: Johnston SL, O'Byrne P, eds. Exacerbations of asthma. London: Parthenon Publishing Group, 2006;(in press).
6. Lister S, Sheppeard V, Morgan G, et al. February asthma outbreaks in NSW: a case control study. Aust NZ J Public Health 2001;255:14-9.
7. Kimbell-Dunn M, Pearce N, Beasley R. Seasonal variation in asthma hospitalizations and death rates in New Zealand. Respirology 2000;5:241-6.
8. Unger L, Harris MC. Stepping stones in allergy. Ann Allergy 1974;32:214-30.
9. Maimonides M. In: Suessman Muntner, eds. Treatise on asthma. Philadelphia: JB Lippincott, 1963:1-2.
10. Floyer JA. A treatise of the asthma, 2nd ed. Printed for R Wilkin and W Innys, 1717.
11. Salter HH. On asthma: its pathology and treatment, London, 1860.
12. Johnston NW, Johnston SL, Dai J, et al. The September epidemic of asthma exacerbations: school children as disease vectors. J Allergy Clin Immunol 2006;117:557-62.
13. Murray CS, Simpson A, Custovic A. Allergens, viruses and asthma exacerbations. Proc Am Thorac Soc 2004;1:99-104.
14. Johnston SL. Overview of virus-induced airway disease. Proc Am Thorac Soc 2005;2:150-6.
15. Gwaltney JM, Hendley JO, Simon G, et al. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med. 1966; 275;1261-8).
16. Hendley JO, Gwaltney JM, Jordan WS. Rhinovirus infections in an industrial population. IV. Infections within families of employees during two fall peaks of respiratory illness. Am J Epidemiol 1969;89:184-96.
17. Dales RE, Schweitzer I, Toogood JH, et al. Respiratory infections and the autumn increase in asthma morbidity. Eur Respir J 1996;9:72-7.
18. Johnston SL, Pattemore PK, Sanderson G, et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med 1996;154:654-60.
19. Johnston NW, Johnston SL, Duncan JM, et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005;112:132-8.
20. Weiss KB. Seasonal trends in US hospitalizations and mortality. JAMA 1990;263:2323-8.
21. Campbell MJ, Holgate ST, Johnston SL. Trends in asthma mortality. BMJ 1997;315:1012.
22. Skobeloff EM, Spivey WH, St Clair SS, et al. The influence of age and sex on asthma admissions. JAMA 1992;268:3437-40.
23. Hyndman SJ, Williams DRR, Merrill SL, et al. Rates of admission to hospital for asthma. BMJ 1994;308:1596-600.
24. Brenner BE, Holmes TM, Mazal B, et al. Relation between phase of the menstrual cycle and asthma presentations in the emergency department. Thorax 2005;60:806-9.
25. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma. A descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999;160:594-9.
26. Manfreda J, Becklake MR, Sears MR, et al. Prevalence of asthma symptoms among adults aged 20-44 years in Canada. Can Med Assoc J 2001;164:995-1001.
27. Panickar JR, Dodd S, Smyth RK, et al. Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000. Thorax 2005;60:1035-8.
28. Getahun D, Demissie K, Rhoads GG. Recent trends in asthma hospitalisation and mortality in the United States. J Asthma 2005;42:373-8.
29. Hales S, Lewis S, Slater T, et al. Prevalence of asthma symptoms in relation to climate in New Zealand. Environ Health Perspect 1998;106:607-10.
30. Weiland SK, Husing A, Strachan DP, et al. Climate and the prevalence of symptoms of asthma, allergic rhinitis, and atopic eczema in children. Occup Environ Med 2004;61:609-15.
31. Ivey M, Simeon D, Juman S, et al. Associations between climate variables and asthma visits to accident and emergency facilities in Trinidad, West Indies. Allergol Int 2001;50:29-33.
32. Hersoug L-G. Viruses as the causative agent related to 'dampness' and the missing link between allergen exposure and the onset of allergic disease. Indoor Air 2005;15:363-6.
33. Dales RE, Cakmak S, Judek S, et al. Influence of outdoor aeroallergens on hospitalization for asthma in Canada. J Allergy Clin Immunol 2004;113:303-6.
34. Higham J, Venables K, Kupek E, et al. Asthma and thunderstorms: description of an epidemic in general practice in Britain using data from a doctor's deputising service in the UK. J Epidemiol Community Health 1997;51:233-8.
35. Dales RE, Cakmak S, Judek S, et al. The role of fungal spores in thunderstorm asthma. Chest 2003;123:745-50.
36. Marks GB, Colquhoun JR, Girgis ST, et al. Thunderstorm outflows preceding epidemics of asthma during spring and summer. Thorax 2001;56:468-71.
37. Anto JM, Sunyer J, Rodriguez-Roisin R, et al. Community outbreaks of asthma associated with inhalation of soybean dust. N Engl J Med 1989;320:1097-102.
38. Thomas KE, Trigg O, Baxter PJ, et al. Factors relating to the development of respiratory symptoms in coffee process workers. Br J Ind Med 1991;48:314-22.
39. Targonski PV, Persky VW, Ramekrishnan V. Effect of environmental molds on risk of death from asthma during the pollen season. J Allergy Clin Immunol 1995;95:955-61.
40. O'Hollaren MT, Yunginger JW, Offord KP, et al. Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma. N Engl J Med 1991;324:359-63.
41. Atkinson RW, Strachan DP. Role of outdoor aeroallergens in asthma exacerbations: epidemiological evidence. Thorax 2004;569:277-8.
42. Jamason PF, Kalkstein LS, Gergen PJ. A synoptic evaluation of asthma hospital admissions in New York City. Am J Respir Crit Care Med 1997;156:1781-8.
43. Peden DB. The epidemiology and genetics of asthma risk associated with air pollution. J Allergy Clin Immunol 2005;115:213-9.
44. Riedl M, Diaz-Sanchez D. Biology of diesel exhaust effects on respiratory function. J Alleray Clin Immunol 2005;115:221-8.
45. Chauhan AJ, Johnston SL. Air pollution and infection in respiratory illness. Br Med Bull 2003;68:95-112.
46. Murray CS, Poletti G, Kebadze T, et al. A study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospitalisation in children. Thorax 2005;61:376-82.
47. Cerveri I, Locatelli F, Zoia MC, et al. International variations in asthma treatment compliance. Eur Respir J 1999;14:288-94.
48. Rabe KF, Adachi M, Lai CKW, et al. Worldwide severity and control of asthma in children and adults: the global Asthma Insights and Reality surveys. J Allergy Clin Immunol 2004;114:40-7.
49. Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in asthma management practices across seven European countries. Respir Med 2002;96:142-9.
50. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol 2001;107:937-44.
51. Parameswaran K, O'Byrne PM, Sears MR. Inhaled corticosteroids for asthma: common clinical quandaries. J Asthma 2003;40:107-18.
52. Tan WC. Viruses in asthma exacerbations. Curr Opin Pulm Med 2004;11:21-6.
53. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005;116:267-73.
54. Gern JE. Rhinovirus infections and asthma. Am J Med 2002;112(Suppl 6A):19-27S.
55. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood. Cochrane Database of Systematic: Reviews 2000;1:CD0011107.
56. Weinberger M. Treatment strategies for viral respiratory infection-induced asthma. J Pediatr 2003;142:S34-9.
57. Doull UM, Lampe FC, Smith S, et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858-62.
58. Reddel H, Ware S, Marks GB, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-9.
59. Grunberg K, Sharon RF, Sont J, et al. Rhinovirus-induced airway inflammation in asthma. Effect of treatment with inhaled corticosteroids before and during experimental infection. Am J Respir Crit Care Med 2001;164:1816-22.
60. Vermeire PA, Rabe KF, Soriano JB, et al. Asthma control and differences in management practices across seven European countries. Respir Med 2002;96:142-9.
61. Cerveri I, Locatelli F, Zoia MC, et al. International variations in asthma management compliance. Eur Respir J 1999;14:288-94.
62. Rennard SI, Farmer SG. Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004;1:88-92.
63. Jones C, Santanello NC, Boccuzzi SJ, et al. Adherence to prescribed treatment for asthma: evidence from pharmacy benefits data. J Asthma 2003;40:93-101.